免费尼古丁替代疗法项目与实施无烟工作场所的成本效益比较
Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.
作者信息
Ong Michael K, Glantz Stanton A
机构信息
VA Palo Alto Health Care System, CA, USA.
出版信息
Am J Public Health. 2005 Jun;95(6):969-75. doi: 10.2105/AJPH.2004.040667.
Abstract
We compared the cost-effectiveness of a free nicotine replacement therapy (NRT) program with a statewide smoke-free workplace policy in Minnesota. We conducted 1-year simulations of costs and benefits. The number of individuals who quit smoking and the quality-adjusted life years (QALYs) were the measures of benefits. After 1 year, a NRT program generated 18,500 quitters at a cost of 7020 dollars per quitter (4440 dollars per QALY), and a smoke-free workplace policy generated 10,400 quitters at a cost of 799 dollars per quitter (506 dollars per QALY). Smoke-free work-place policies are about 9 times more cost-effective per new nonsmoker than free NRT programs are. Smoke-free workplace policies should be a public health funding priority, even when the primary goal is to promote individual smoking cessation.
摘要
我们比较了明尼苏达州免费尼古丁替代疗法（NRT）项目与全州范围内无烟工作场所政策的成本效益。我们进行了为期1年的成本和效益模拟。戒烟人数和质量调整生命年（QALY）作为效益衡量指标。1年后，NRT项目使18500人戒烟，每位戒烟者的成本为7020美元（每QALY为4440美元），而无烟工作场所政策使10400人戒烟，每位戒烟者的成本为799美元（每QALY为506美元）。无烟工作场所政策每新增一名不吸烟者的成本效益约为免费NRT项目的9倍。即使主要目标是促进个人戒烟，无烟工作场所政策也应成为公共卫生资金的优先投入方向。
相似文献
1
Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.免费尼古丁替代疗法项目与实施无烟工作场所的成本效益比较
Am J Public Health. 2005 Jun;95(6):969-75. doi: 10.2105/AJPH.2004.040667.
2
Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.面对面戒烟干预措施的成本效益：一项动态建模研究。
Value Health. 2005 May-Jun;8(3):178-90. doi: 10.1111/j.1524-4733.2005.04008.x.
3
Cardiovascular health and economic effects of smoke-free workplaces.无烟工作场所对心血管健康和经济的影响。
Am J Med. 2004 Jul 1;117(1):32-8. doi: 10.1016/j.amjmed.2004.02.029.
4
The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.吸烟史框架：说明戒烟尝试、戒烟方法和新烟民对吸烟流行率、挽救的预期寿命、节省的医疗费用、规划成本、成本效益和投资回报的影响。
Am J Health Promot. 2011 Sep-Oct;26(1):e11-23. doi: 10.4278/ajhp.101014-QUAN-337.
5
6
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.希腊伐伦克林与安非他酮、尼古丁替代疗法和非药物戒烟的成本效益比较。
Clin Ther. 2012 Aug;34(8):1803-14. doi: 10.1016/j.clinthera.2012.07.002. Epub 2012 Jul 20.
7
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.安非他酮在戒烟健康项目中的成本效益：瑞典的模拟模型结果
Chest. 2006 Mar;129(3):651-60. doi: 10.1378/chest.129.3.651.
8
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.戒烟辅助工具的成本与效益：为澳大利亚尼古丁替代疗法的公共报销提供依据。
Tob Control. 2007 Aug;16(4):255-60. doi: 10.1136/tc.2006.017657.
9
Reductions in tobacco smoke pollution and increases in support for smoke-free public places following the implementation of comprehensive smoke-free workplace legislation in the Republic of Ireland: findings from the ITC Ireland/UK Survey.爱尔兰共和国实施全面无烟工作场所立法后，烟草烟雾污染减少，对无烟公共场所的支持增加：来自爱尔兰/英国国际烟草控制调查的结果
Tob Control. 2006 Jun;15 Suppl 3(Suppl 3):iii51-8. doi: 10.1136/tc.2005.013649.
10
Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.经皮尼古丁贴片作为医生戒烟咨询辅助手段的成本效益。
JAMA. 1996 Apr 24;275(16):1247-51.
引用本文的文献
1
Pharmaceuticalisation as the tobacco industry's endgame.将医药化作为烟草行业的最终目标。
BMJ Glob Health. 2024 Feb 5;9(2):e013866. doi: 10.1136/bmjgh-2023-013866.
2
Social and racial inequalities in diabetes and cancer in the United States.美国糖尿病和癌症的社会和种族不平等。
Front Public Health. 2023 Jul 19;11:1178979. doi: 10.3389/fpubh.2023.1178979. eCollection 2023.
3
Influence of Disclosed and Undisclosed Funding Sources in Tobacco Harm Reduction Discourse: A Social Network Analysis.披露和未披露的资金来源对减少烟草危害话语的影响：社会网络分析。
Nicotine Tob Res. 2023 Nov 22;25(12):1829-1837. doi: 10.1093/ntr/ntac250.
4
Understanding Hesitation to Use Nicotine Replacement Therapy: A Content Analysis of Posts in Online Tobacco-Cessation Support Groups.理解对尼古丁替代疗法的使用犹豫：对在线戒烟支持小组帖子的内容分析。
Am J Health Promot. 2023 Jan;37(1):30-38. doi: 10.1177/08901171221113835. Epub 2022 Jul 11.
5
Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model.尼古丁替代疗法依从性的障碍和促进因素：使用能力、机会、动机和行为 (COM-B) 模型进行的系统评价和分析。
Int J Environ Res Public Health. 2020 Nov 30;17(23):8895. doi: 10.3390/ijerph17238895.
6
Financial benefit of a smoking cessation program prior to elective colorectal surgery.择期结直肠手术前戒烟计划的经济效益。
J Surg Res. 2017 Jul;215:183-189. doi: 10.1016/j.jss.2017.03.067. Epub 2017 Apr 7.
7
Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.基于模型的戒烟经济评估及其在新环境中的可转移性：一项系统综述。
Addiction. 2017 Jun;112(6):946-967. doi: 10.1111/add.13748. Epub 2017 Feb 15.
8
Nicotine dependence among workers: Is it a time for smoke-free workplaces!工人中的尼古丁依赖：是时候设立无烟工作场所了！
Lung India. 2016 Sep-Oct;33(5):477-8. doi: 10.4103/0970-2113.188959.
9
Medical costs and quality-adjusted life years associated with smoking: a systematic review.与吸烟相关的医疗成本和质量调整生命年：一项系统综述。
BMC Public Health. 2016 Jul 27;16:646. doi: 10.1186/s12889-016-3319-z.
10
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.吸烟及降低吸烟率的经济影响：证据综述
Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015.
本文引用的文献
1
Public health foundations and the tobacco industry: lessons from Minnesota.公共卫生基金会与烟草行业：明尼苏达州的经验教训
Tob Control. 2004 Sep;13(3):228-36. doi: 10.1136/tc.2003.006866.
2
Cardiovascular health and economic effects of smoke-free workplaces.无烟工作场所对心血管健康和经济的影响。
Am J Med. 2004 Jul 1;117(1):32-8. doi: 10.1016/j.amjmed.2004.02.029.
3
Public health under attack: the American Stop Smoking Intervention Study (ASSIST) and the tobacco industry.公共卫生受到攻击：美国戒烟干预研究（ASSIST）与烟草行业。
Am J Public Health. 2004 Feb;94(2):240-50. doi: 10.2105/ajph.94.2.240.
4
Impact of UK National Health Service smoking cessation services: variations in outcomes in England.英国国民医疗服务体系戒烟服务的影响：英格兰地区的结果差异
Tob Control. 2003 Sep;12(3):296-301. doi: 10.1136/tc.12.3.296.
5
British Columbia capital regional district 100% smokefree bylaw: a successful public health campaign despite industry opposition.不列颠哥伦比亚省首府地区100%无烟法规：尽管遭到行业反对，却是一场成功的公共卫生运动。
Tob Control. 2003 Sep;12(3):264-8. doi: 10.1136/tc.12.3.264.
6
The Duluth clean indoor air ordinance: problems and success in fighting the tobacco industry at the local level in the 21st century.德卢斯清洁室内空气条例：21世纪在地方层面与烟草业作斗争中的问题与成效
Am J Public Health. 2003 Aug;93(8):1214-21. doi: 10.2105/ajph.93.8.1214.
7
Cost-effectiveness analysis of the first-line therapies for nicotine dependence.尼古丁依赖一线治疗的成本效益分析
Eur J Clin Pharmacol. 2003 Jul;59(3):201-6. doi: 10.1007/s00228-003-0610-6. Epub 2003 May 21.
8
Prevalence of current cigarette smoking among adults and changes in prevalence of current and some day smoking--United States, 1996-2001.1996 - 2001年美国成年人当前吸烟率以及当前和曾经吸烟率的变化情况
MMWR Morb Mortal Wkly Rep. 2003 Apr 11;52(14):303-4, 306-7.
9
Evidence of real-world effectiveness of a telephone quitline for smokers.吸烟者电话戒烟热线的真实世界有效性证据。
N Engl J Med. 2002 Oct 3;347(14):1087-93. doi: 10.1056/NEJMsa020660.
10
Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial.尼古丁替代疗法用于减少不愿戒烟的吸烟者的香烟消费量：一项随机试验。
J Clin Psychopharmacol. 2002 Oct;22(5):487-95. doi: 10.1097/00004714-200210000-00008.
Zotero 插件